Page 16 - பலதரப்பட்ட சங்கம் க்கு சைகடெலிக் ஆய்வுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

comments Supposedly, we are living through a psychedelic renaissance. From ketamine antidepressants to MDMA-assisted psychotherapy, the medical use of psychedelic drugs is portrayed in the media as a boon for the mental health profession, which reports seemingly miraculous results for treating some of the most significant mental health issues facing our time. The FDA has granted breakthrough status for both psilocybin and MDMA as treatments, and venture capitalists are placing bets on psychedelics to curb the trillion dollar public health burden. As psychedelic advocates and practitioners with decades of experience, having worked with thousands of people, we believe we need a serious examination of whether the current mental health industry is the place for psychedelic drugs. Looking at the industry historically, there have been repeated claims of breakthrough modalities that would bring psychiatry into the realm of medical science. Yet none of these claims have demonstrated a

Allen francesThomas inselBonnie burstowRoss ellenhornMultidisciplinary association for psychedelic studiesMultidisciplinary associationPsychedelic studiesPost traumatic stress disorderStatistical manualMental disordersHumanistic psychologyStatistics manualBig pharmaOrdinary lifeஆலன் பிரான்சிஸ்பலதரப்பட்ட சங்கம் க்கு சைகடெலிக் ஆய்வுகள்